Variant report
Variant | nsv961775 |
---|---|
Chromosome Location | chr2:52657779-52665204 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75473826 | chr2:52657809-52657810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs79834929 | chr2:52657813-52657814 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs567573387 | chr2:52657828-52657829 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547577465 | chr2:52657833-52657834 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs12471751 | chr2:52657851-52657852 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs189779778 | chr2:52657853-52657854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs550132440 | chr2:52657858-52657859 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569949227 | chr2:52657864-52657865 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs76182822 | chr2:52657921-52657922 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs199863050 | chr2:52658037-52658038 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs552298150 | chr2:52658047-52658048 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182992324 | chr2:52658055-52658056 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73931325 | chr2:52658087-52658088 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs200484883 | chr2:52658110-52658111 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554723796 | chr2:52658118-52658119 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374632021 | chr2:52658185-52658186 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs377644788 | chr2:52658214-52658215 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537341887 | chr2:52658220-52658221 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188689701 | chr2:52658244-52658245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573972035 | chr2:52658260-52658261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577469367 | chr2:52658308-52658309 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs374079041 | chr2:52658331-52658332 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs544946555 | chr2:52658411-52658412 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs116217193 | chr2:52658421-52658422 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572143056 | chr2:52658422-52658423 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541155622 | chr2:52658424-52658425 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563177581 | chr2:52658425-52658426 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs576302866 | chr2:52658450-52658451 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs55932376 | chr2:52658460-52658461 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs148999208 | chr2:52658463-52658464 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144619138 | chr2:52658492-52658493 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552516340 | chr2:52658496-52658497 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565768172 | chr2:52658530-52658531 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs569271603 | chr2:52658547-52658548 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138519341 | chr2:52658576-52658577 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs548317878 | chr2:52658581-52658582 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs141681219 | chr2:52658592-52658593 | Weak transcription ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs537198646 | chr2:52658612-52658613 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557280171 | chr2:52658625-52658626 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs13411972 | chr2:52658635-52658636 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs577429894 | chr2:52658683-52658684 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs539764419 | chr2:52658711-52658712 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs558503113 | chr2:52658726-52658727 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs374441167 | chr2:52658744-52658745 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs12713202 | chr2:52658797-52658798 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs12713203 | chr2:52658801-52658802 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs74832945 | chr2:52658840-52658841 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574595977 | chr2:52658845-52658846 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs543569539 | chr2:52658859-52658860 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs563360884 | chr2:52658869-52658870 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:52655400-52658200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr2:52655600-52658400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr2:52655600-52659000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr2:52655800-52658200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
5 | chr2:52655800-52659200 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
6 | chr2:52656000-52667200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
7 | chr2:52656200-52658000 | Enhancers | Primary hematopoietic stem cells | blood |
8 | chr2:52656200-52658000 | Enhancers | Hela-S3 | cervix |
9 | chr2:52656800-52658400 | Enhancers | Liver | Liver |
10 | chr2:52657000-52657800 | Weak transcription | Fetal Intestine Large | intestine |
11 | chr2:52657800-52658400 | Enhancers | Fetal Intestine Large | intestine |
12 | chr2:52658200-52658600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr2:52658200-52663000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr2:52658400-52658600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr2:52658400-52658800 | Flanking Active TSS | Liver | Liver |
16 | chr2:52658600-52659000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr2:52658600-52667200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr2:52658800-52659000 | Active TSS | Liver | Liver |
19 | chr2:52659000-52659200 | Flanking Active TSS | Liver | Liver |
20 | chr2:52662800-52666000 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |
21 | chr2:52663000-52663200 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
22 | chr2:52664600-52665000 | ZNF genes & repeats | H9 Cell Line | embryonic stem cell |
23 | chr2:52665000-52668200 | Weak transcription | H9 Cell Line | embryonic stem cell |